FGF receptor agonist compounds corresponding to the general formula: M-L-M in which M and M, which may be identical or different, each represent, independently of one another, a monomer unit M, and L represents a linker group which covalently links M and M, wherein said monomer unit corresponds to the general formula M which follows: (I). Preparation process and therapeutic use.